Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins
Live birth rate per woman · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in live birth rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes onlyRR 1.21 [0.83, 1.78]5 studies · 505 participantsLow